These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
494 related items for PubMed ID: 20403082
1. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice. Koda K, Ago Y, Cong Y, Kita Y, Takuma K, Matsuda T. J Neurochem; 2010 Jul; 114(1):259-70. PubMed ID: 20403082 [Abstract] [Full Text] [Related]
2. Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats. Ruocco LA, Carnevale UA, Treno C, Sadile AG, Melisi D, Arra C, Ibba M, Schirru C, Carboni E. Behav Brain Res; 2010 Jun 26; 210(1):99-106. PubMed ID: 20156489 [Abstract] [Full Text] [Related]
3. Effects of acute and chronic administration of venlafaxine and desipramine on extracellular monoamine levels in the mouse prefrontal cortex and striatum. Higashino K, Ago Y, Umehara M, Kita Y, Fujita K, Takuma K, Matsuda T. Eur J Pharmacol; 2014 Apr 15; 729():86-93. PubMed ID: 24561044 [Abstract] [Full Text] [Related]
4. Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat. Swanson CJ, Perry KW, Koch-Krueger S, Katner J, Svensson KA, Bymaster FP. Neuropharmacology; 2006 May 15; 50(6):755-60. PubMed ID: 16427661 [Abstract] [Full Text] [Related]
5. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW. Neuropsychopharmacology; 2002 Nov 15; 27(5):699-711. PubMed ID: 12431845 [Abstract] [Full Text] [Related]
6. Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex. Horner WE, Johnson DE, Schmidt AW, Rollema H. Eur J Pharmacol; 2007 Mar 08; 558(1-3):96-7. PubMed ID: 17198700 [Abstract] [Full Text] [Related]
7. Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain. Easton N, Steward C, Marshall F, Fone K, Marsden C. Neuropharmacology; 2007 Feb 08; 52(2):405-14. PubMed ID: 17020775 [Abstract] [Full Text] [Related]
8. Chronic treatment with a dopamine uptake blocker changes dopamine and acetylcholine but not glutamate and GABA concentrations in prefrontal cortex, striatum and nucleus accumbens of the awake rat. Hernández LF, Segovia G, Mora F. Neurochem Int; 2008 Feb 08; 52(3):457-69. PubMed ID: 17881090 [Abstract] [Full Text] [Related]
9. Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine. Tzavara ET, Bymaster FP, Overshiner CD, Davis RJ, Perry KW, Wolff M, McKinzie DL, Witkin JM, Nomikos GG. Mol Psychiatry; 2006 Feb 08; 11(2):187-95. PubMed ID: 16231039 [Abstract] [Full Text] [Related]
10. [Towards an understanding of the molecular mechanisms underlying the pharmacological treatments of attention deficit hyperactivity disorder]. Castellanos FX, Acosta MT. Rev Neurol; 2011 Mar 01; 52 Suppl 1():S155-60. PubMed ID: 21365598 [Abstract] [Full Text] [Related]
11. Reduced prefrontal dopaminergic activity in valproic acid-treated mouse autism model. Hara Y, Takuma K, Takano E, Katashiba K, Taruta A, Higashino K, Hashimoto H, Ago Y, Matsuda T. Behav Brain Res; 2015 Aug 01; 289():39-47. PubMed ID: 25907743 [Abstract] [Full Text] [Related]
12. High-sensitive liquid chromatographic method for determination of neuronal release of serotonin, noradrenaline and dopamine monitored by microdialysis in the rat prefrontal cortex. Yoshitake T, Yoshitake S, Fujino K, Nohta H, Yamaguchi M, Kehr J. J Neurosci Methods; 2004 Dec 30; 140(1-2):163-8. PubMed ID: 15589346 [Abstract] [Full Text] [Related]
13. Effects of serotonin-norepinephrine reuptake inhibitors on locomotion and prefrontal monoamine release in spontaneously hypertensive rats. Umehara M, Ago Y, Fujita K, Hiramatsu N, Takuma K, Matsuda T. Eur J Pharmacol; 2013 Feb 28; 702(1-3):250-7. PubMed ID: 23376565 [Abstract] [Full Text] [Related]
14. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AF, Kelley AE, Schmeichel B, Hamilton C, Spencer RC. Biol Psychiatry; 2006 Nov 15; 60(10):1111-20. PubMed ID: 16806100 [Abstract] [Full Text] [Related]
15. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal. Devoto P, Flore G, Pira L, Diana M, Gessa GL. Psychopharmacology (Berl); 2002 Mar 15; 160(2):220-4. PubMed ID: 11875641 [Abstract] [Full Text] [Related]
16. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. Wilens TE. J Clin Psychopharmacol; 2008 Jun 15; 28(3 Suppl 2):S46-53. PubMed ID: 18480677 [Abstract] [Full Text] [Related]
17. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Devoto P, Flore G, Pani L, Gessa GL. Mol Psychiatry; 2001 Nov 15; 6(6):657-64. PubMed ID: 11673793 [Abstract] [Full Text] [Related]
18. Cocaine treatment increases expression of a 40 kDa catecholamine-regulated protein in discrete brain regions. Sharan N, Chong VZ, Nair VD, Mishra RK, Hayes RJ, Gardner EL. Synapse; 2003 Jan 15; 47(1):33-44. PubMed ID: 12422371 [Abstract] [Full Text] [Related]
19. The effects of atomoxetine and methylphenidate on the prepulse inhibition of the acoustic startle response in mice. Woo H, Park SJ, Lee Y, Kwon G, Gao Q, Lee HE, Ahn YJ, Shin CY, Cheong JH, Ryu JH. Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct 03; 54():206-15. PubMed ID: 24953433 [Abstract] [Full Text] [Related]
20. In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine. Jordan S, Kramer GL, Zukas PK, Moeller M, Petty F. Synapse; 1994 Dec 03; 18(4):294-7. PubMed ID: 7886621 [Abstract] [Full Text] [Related] Page: [Next] [New Search]